Fanny Collaud

2.0k total citations
32 papers, 1.1k citations indexed

About

Fanny Collaud is a scholar working on Genetics, Molecular Biology and Physiology. According to data from OpenAlex, Fanny Collaud has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 19 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Fanny Collaud's work include Virus-based gene therapy research (22 papers), RNA Interference and Gene Delivery (10 papers) and Lysosomal Storage Disorders Research (8 papers). Fanny Collaud is often cited by papers focused on Virus-based gene therapy research (22 papers), RNA Interference and Gene Delivery (10 papers) and Lysosomal Storage Disorders Research (8 papers). Fanny Collaud collaborates with scholars based in France, United States and Italy. Fanny Collaud's co-authors include Giuseppe Ronzitti, Federico Mingozzi, Christian Leborgne, Séverine Charles, Laetitia van Wittenberghe, Marcelo Simon Sola, Solenne Marmier, Alban Vignaud, Helena Costa Verdera and P. Véron and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Fanny Collaud

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fanny Collaud France	18	705	700	239	154	151	32	1.1k
Shyrie Edmonson United States	9	755 1.1×	661 0.9×	265 1.1×	111 0.7×	125 0.8×	13	969
Yunyu Spence United States	12	827 1.2×	766 1.1×	306 1.3×	125 0.8×	86 0.6×	16	1.1k
Séverine Charles France	13	468 0.7×	458 0.7×	142 0.6×	113 0.7×	88 0.6×	20	814
Marcelo Simon Sola France	8	428 0.6×	406 0.6×	134 0.6×	97 0.6×	80 0.5×	11	621
Hengjun Chao United States	11	737 1.0×	706 1.0×	318 1.3×	59 0.4×	128 0.8×	17	994
M. Kyle Cromer United States	11	443 0.6×	992 1.4×	255 1.1×	125 0.8×	68 0.5×	17	1.2k
Gilliane Chadeuf France	14	531 0.8×	604 0.9×	169 0.7×	79 0.5×	84 0.6×	29	822
Samantha Scaramuzza Italy	17	555 0.8×	520 0.7×	320 1.3×	63 0.4×	33 0.2×	29	1.1k
S. Hardy United States	3	287 0.4×	473 0.7×	137 0.6×	60 0.4×	68 0.5×	6	729
George Buchlis United States	13	339 0.5×	459 0.7×	367 1.5×	61 0.4×	78 0.5×	15	869

Countries citing papers authored by Fanny Collaud

Since Specialization

Citations

This map shows the geographic impact of Fanny Collaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Collaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Collaud more than expected).

Fields of papers citing papers by Fanny Collaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Collaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Collaud. The network helps show where Fanny Collaud may publish in the future.

Co-authorship network of co-authors of Fanny Collaud

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Collaud. A scholar is included among the top collaborators of Fanny Collaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Collaud. Fanny Collaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Collaud, Fanny, Verónica Jiménez, Xavier León, et al.. (2025). A myotropic AAV vector combined with skeletal muscle cis-regulatory elements improve glycogen clearance in mouse models of Pompe disease. Molecular Therapy — Methods & Clinical Development. 33(2). 101464–101464.

Shi, Xiaoxia, Giulia Bortolussi, Fanny Collaud, et al.. (2024). Repeated dosing of AAV-mediated liver gene therapy in juvenile rat and mouse models of Crigler-Najjar syndrome type I. Molecular Therapy — Methods & Clinical Development. 32(4). 101363–101363. 2 indexed citations

Vidal, Pierre, Benjamin Bertin, Evelyne Gicquel, et al.. (2023). Muscle‐specific, liver‐detargeted adeno‐associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa^−/− mice. Journal of Inherited Metabolic Disease. 47(1). 119–134. 9 indexed citations

Barbon, Elena, Charlotte Kawecki, Solenne Marmier, et al.. (2021). Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor. Gene Therapy. 30(3-4). 245–254. 25 indexed citations

Barbon, Elena, Jean‐François Ottavi, Charlotte Kawecki, et al.. (2020). Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors. EMBO Molecular Medicine. 12(4). e11298–e11298. 19 indexed citations

Véron, P., Christian Leborgne, Jack‐Yves Deschamps, et al.. (2020). Capsid-specific removal of circulating antibodies to adeno-associated virus vectors. Scientific Reports. 10(1). 864–864. 80 indexed citations

Colella, Pasqualina, Manuel J. Gómez, Maria Grazia Biferi, et al.. (2020). Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects. EBioMedicine. 61. 103052–103052. 18 indexed citations

Aronson, Sem J., Remco van Dijk, Giulia Bortolussi, et al.. (2020). A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene. Molecular Therapy — Methods & Clinical Development. 18. 250–258. 14 indexed citations

Boisgérault, Florence, Corrado Guarnaccia, Alessandra Iaconcig, et al.. (2020). Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector. Molecular Therapy — Methods & Clinical Development. 20. 169–180. 14 indexed citations

10.

Chappert, Pascal, Dominique Urbain, Fanny Collaud, et al.. (2019). Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity. JCI Insight. 4(11). 17 indexed citations

11.

Poupiot, Jérôme, Helena Costa Verdera, Romain Hardet, et al.. (2019). Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in Muscle. Molecular Therapy — Methods & Clinical Development. 15. 83–100. 19 indexed citations

12.

Ronzitti, Giuseppe, Fanny Collaud, Pascal Laforêt, & Federico Mingozzi. (2019). Progress and challenges of gene therapy for Pompe disease. Annals of Translational Medicine. 7(13). 287–287. 35 indexed citations

13.

Orefice, Nicola Salvatore, Benoît Souchet, Jérôme Braudeau, et al.. (2019). Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain. Molecular Therapy — Methods & Clinical Development. 14. 237–251. 39 indexed citations

14.

Leborgne, Christian, Sylvie Boutin, Fanny Collaud, et al.. (2018). Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients. Cellular Immunology. 342. 103780–103780. 41 indexed citations

15.

Boisgérault, Florence, Romain Hardet, Solenne Marmier, et al.. (2018). Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications. 9(1). 4098–4098. 203 indexed citations

16.

Kuranda, Klaudia, Christian Leborgne, Romain Hardet, et al.. (2018). Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. Journal of Clinical Investigation. 128(12). 5267–5279. 78 indexed citations

17.

Fitzpatrick, Zachary, Christian Leborgne, Elena Barbon, et al.. (2018). Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction. Molecular Therapy — Methods & Clinical Development. 9. 119–129. 136 indexed citations

18.

Colella, Pasqualina, Helena Costa Verdera, Francesco Puzzo, et al.. (2018). AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice. Molecular Therapy — Methods & Clinical Development. 12. 85–101. 54 indexed citations

19.

Ronzitti, Giuseppe, Giulia Bortolussi, Remco van Dijk, et al.. (2016). A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome. Molecular Therapy — Methods & Clinical Development. 3. 16049–16049. 48 indexed citations

20.

Meliani, Amine, Florence Boisgérault, Giuseppe Ronzitti, et al.. (2016). 77. Antigen-Specific Modulation of Capsid Immunogenicity with Tolerogenic Nanoparticles Results in Successful AAV Vector Readministration. Molecular Therapy. 24. S34–S34. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact